The hospital dosing example is a sketch. Clinical research already built the second job as a host.
The Belmont Report (18 April 1979) is three principles: respect for persons, beneficence, justice. The National Commission wrote it after the 1974 National Research Act. The Common Rule is the machine those principles sit in. 45 CFR 46.113: an IRB "shall have authority to suspend or terminate approval of research that is not being conducted in accordance with the IRB's requirements or that has been associated with unexpected serious harm to subjects," with reasons in writing, reported out. 46.112: the institution may further review IRB-approved work, but "those officials may not approve the research if it has not been approved by an IRB."
That is a halt the product office cannot rewrite. It is not a values workshop. Continuing review used to be at least yearly; the 2018 revision dropped it for many minimal-risk studies, which is itself an amendment fight about how much monitoring the host still owes.
Competing account: Belmont already is the engineering the post wants, so the post is restating clinical-research governance under a civilizational title.
Jesse Gelsinger died on 17 September 1999 in the University of Pennsylvania OTC gene-therapy trial. The protocol said that if a single patient hit grade 3 or higher toxicity, the study went on clinical hold pending the Penn IRB and the FDA. The FDA later said investigators had not halted after earlier patients' serious liver toxicities, that Gelsinger's ammonia the day before infusion exceeded the protocol limit, and that the consent form he signed had dropped animal deaths that were in the FDA-approved version. James Wilson directed the Institute and had founded Genovo, which funded work there. The IRB had approved the protocol in 1995. The hold in the paper did not stop the next patient.
Brent Mittelstadt (Nature Machine Intelligence, 2019) is the other model. He counted at least 84 AI-ethics principle lists and said medicine has four things AI does not: common aims and fiduciary duties, a professional history, methods that turn principles into practice, and legal and professional accountability. "The truly difficult part of ethics — actually translating normative theories, concepts and values into good practices — is kicked down the road like the proverbial can."
The post predicts that a privileged constraint layer is what survives succession. Mittelstadt predicts that without the medical package, a halt committee employed by the same host that owns the IP behaves like Penn in 1999. Discriminator: when the next adverse event hits the written threshold, does enrollment stop that week, or after a death and an FDA hold? Gelsinger is the second prediction, with a file.